{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:52:12Z","timestamp":1794340332763,"version":"4.9.0"},"reference-count":127,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative option for patients with high-risk malignancies and nonmalignant disorders. Long-term survival depends on robust immune reconstitution (IR), which governs overall immune homeostasis and risks of infection, graft-versus-host disease, and relapse. However, despite its centrality to posttransplant outcomes, IR is not consistently monitored across transplant centers, limiting ability to generate meaningful, comparable, and translatable data. This review synthesizes current knowledge on numerical and functional IR milestones after allo-HCT, with a primary focus on flow cytometry-based monitoring of key immune cell subsets. Importantly, early CD4+ T-cell recovery (achieving &amp;gt;50 cells per \u03bcL by day 100 after transplant), is supported by strong clinical evidence and correlates with improved outcomes. Although emerging data suggest that additional subsets (CD8+ T cells, natural killer cells, B cells, na\u00efve and recent thymic emigrant T cells, and \u03b3\u03b4 T cells) may also influence clinical trajectories, further harmonized, multicenter studies are needed to validate prognostic relevance across transplant settings. We propose practical, evidence-based guidelines for IR monitoring, including recommended time points, preferred assays, and flow cytometry panel components. Additionally, we highlight modifiable factors (eg, immunosuppressive drug exposures, graft manipulation) offering interventional opportunities for influencing IR. Harmonized monitoring strategies will support robust correlation between IR and clinical outcomes, guide real-time risk stratification, and facilitate the development of targeted, individualized transplant approaches. Standardization efforts led by consortia and registries are essential for advancing knowledge and optimizing care. We provide a roadmap for implementing uniform IR monitoring to improve outcomes and quality of life for allo-HCT recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016915","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T18:59:07Z","timestamp":1756925947000},"page":"6141-6157","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9886-8750","authenticated-orcid":false,"given":"Taymour","family":"Hammoudi","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Section of Hematology, Oncology, Bone Marrow Transplant Cellular Therapeutics, University of Colorado Anschutz Medical Campus, Aurora, CO"},{"name":"2Center for Cancer and Blood Disorders, Children\u2019s Hospital of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-142X","authenticated-orcid":false,"given":"Silvia","family":"Nucera","sequence":"additional","affiliation":[{"name":"3Pediatric Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1526-022X","authenticated-orcid":false,"given":"Alexandre G.","family":"Troullioud Lucas","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Transplantation and Cellular Therapy, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9649-6498","authenticated-orcid":false,"given":"Marc","family":"Ansari","sequence":"additional","affiliation":[{"name":"5Department of Pediatrics, Gynecology and Obstetrics, Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland"},{"name":"6Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-0610","authenticated-orcid":false,"given":"Adriana","family":"Balduzzi","sequence":"additional","affiliation":[{"name":"3Pediatric Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori, Monza, Italy"},{"name":"7University of Milano-Bicocca, School of Medicine and Surgery, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-436X","authenticated-orcid":false,"given":"Alice","family":"Bertaina","sequence":"additional","affiliation":[{"name":"8Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-4501","authenticated-orcid":false,"given":"Jochen","family":"Buechner","sequence":"additional","affiliation":[{"name":"9Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1070-8486","authenticated-orcid":false,"given":"Selim","family":"Corbacioglu","sequence":"additional","affiliation":[{"name":"10Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital Regensburg, University of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Hugues","family":"Dalle","sequence":"additional","affiliation":[{"name":"11Paediatric Haematology and Immunology Department, Robert-Debr\u00e9 Academic Hospital, Groupe Hospitalier Universitaire Assistance Publique-H\u00f4pitaux de Paris Nord, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-5799","authenticated-orcid":false,"given":"Krzystof","family":"Kalwak","sequence":"additional","affiliation":[{"name":"12Department of Pediatric Hematology\/Oncology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland"},{"name":"13Pediatric Diseases Working Party, European Bone Marrow Transplantation Society, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6693-5392","authenticated-orcid":false,"given":"Dean","family":"Lee","sequence":"additional","affiliation":[{"name":"14Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-7828","authenticated-orcid":false,"given":"John E.","family":"Levine","sequence":"additional","affiliation":[{"name":"15The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-5620","authenticated-orcid":false,"given":"Caroline A.","family":"Lindemans","sequence":"additional","affiliation":[{"name":"16Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-3654","authenticated-orcid":false,"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"17Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Ges\u00f9 Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Meisel","sequence":"additional","affiliation":[{"name":"18Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nierkens","sequence":"additional","affiliation":[{"name":"16Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"19Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3777-0394","authenticated-orcid":false,"given":"Giorgio","family":"Ottaviano","sequence":"additional","affiliation":[{"name":"3Pediatric Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Perez-Martinez","sequence":"additional","affiliation":[{"name":"20Pediatric Hemato-Oncology Unit, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5107-5123","authenticated-orcid":false,"given":"Herbert","family":"Pichler","sequence":"additional","affiliation":[{"name":"21Department of Pediatrics and Adolescent Medicine, St Anna Children's Hospital, Medical University of Vienna, Vienna, Austria"},{"name":"22St Anna Children's Cancer Research Institute, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-5728","authenticated-orcid":false,"given":"Susan E.","family":"Prockop","sequence":"additional","affiliation":[{"name":"23Dana Farber\/Boston Children\u2019s Hospital Center for Cancer and Blood Disorders, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-8420","authenticated-orcid":false,"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[{"name":"24Huntsman Cancer Institute\/Intermountain Primary Children's Hospital, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie-An M.","family":"Talano","sequence":"additional","affiliation":[{"name":"25Department of Pediatric Hematology\/Oncology and Bone Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Tewari","sequence":"additional","affiliation":[{"name":"26Department of Paediatric Oncology\/Haematology, Royal Marsden NHS Foundation Trust Sutton, Sutton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0001-6438","authenticated-orcid":false,"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[{"name":"27Michael Cuccione Cancer Research Program, BC Children\u2019s Hospital Research Institute\/University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-9080","authenticated-orcid":false,"given":"Nirali N.","family":"Shah","sequence":"additional","affiliation":[{"name":"28Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-5917","authenticated-orcid":false,"given":"Michael R.","family":"Verneris","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Section of Hematology, Oncology, Bone Marrow Transplant Cellular Therapeutics, University of Colorado Anschutz Medical Campus, Aurora, CO"},{"name":"2Center for Cancer and Blood Disorders, Children\u2019s Hospital of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-6952","authenticated-orcid":false,"given":"Jaap Jan","family":"Boelens","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Transplantation and Cellular Therapy, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"2025120910563027700_bib1","doi-asserted-by":"crossref","first-page":"786017","DOI":"10.3389\/fped.2021.786017","article-title":"Immune reconstitution after allogeneic haematopoietic cell transplantation: from observational studies to targeted interventions","volume":"9","author":"Yanir","year":"2021","journal-title":"Front Pediatr"},{"issue":"7","key":"2025120910563027700_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/1744666X.2019.1612746","article-title":"Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources","volume":"15","author":"Elfeky","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"issue":"6435","key":"2025120910563027700_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1126\/science.aau8694","article-title":"Immunity as a continuum of archetypes","volume":"364","author":"Mujal","year":"2019","journal-title":"Science"},{"issue":"4","key":"2025120910563027700_bib4","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(17)30029-7","article-title":"Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis","volume":"4","author":"Admiraal","year":"2017","journal-title":"Lancet Haematol"},{"issue":"2","key":"2025120910563027700_bib5","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/S2352-3026(21)00375-6","article-title":"Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial","volume":"9","author":"Admiraal","year":"2022","journal-title":"Lancet Haematol"},{"issue":"9","key":"2025120910563027700_bib6","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/bloodadvances.2024014836","article-title":"Improved survival with model-based dosing of anti-thymocyte globulin in pediatric hematopoietic cell transplantation","volume":"9","author":"Admiraal","year":"2025","journal-title":"Blood Adv"},{"issue":"9","key":"2025120910563027700_bib7","first-page":"2854","article-title":"Anti-T-lymphocyte globulin exposure is associated with acute graft-versus-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study","volume":"109","author":"Oostenbrink","year":"2024","journal-title":"Haematologica"},{"issue":"3","key":"2025120910563027700_bib8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/bloodadvances.2021005584","article-title":"Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation","volume":"6","author":"Lakkaraja","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"2025120910563027700_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00281-020-00828-7","article-title":"The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment","volume":"43","author":"Velardi","year":"2021","journal-title":"Semin Immunopathol"},{"issue":"7","key":"2025120910563027700_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/sctm.18-0248","article-title":"Concise review: boosting T-cell reconstitution following allogeneic transplantation-current concepts and future perspectives","volume":"8","author":"Simons","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"2025120910563027700_bib11","doi-asserted-by":"crossref","first-page":"1059481","DOI":"10.3389\/fimmu.2022.1059481","article-title":"Are homeostatic mechanisms aiding the reconstitution of the T-cell pool during lymphopenia in humans?","volume":"13","author":"Baliu-Piqu\u00e9","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"2025120910563027700_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/bloodadvances.2019001021","article-title":"Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation","volume":"4","author":"Ando","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2025120910563027700_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10238-023-01270-3","article-title":"Early T-cell reconstitution predicts risk of EBV reactivation after allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Huang","year":"2024","journal-title":"Clin Exp Med"},{"key":"2025120910563027700_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fimmu.2019.00334","article-title":"Naive and stem cell memory T cell subset recovery reveals opposing reconstitution patterns in CD4 and CD8 T cells in chronic graft vs. host disease","volume":"10","author":"Soares","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"2025120910563027700_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood"},{"issue":"12","key":"2025120910563027700_bib16","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/tri.13494","article-title":"A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors","volume":"32","author":"Nakamae","year":"2019","journal-title":"Transpl Int"},{"issue":"3","key":"2025120910563027700_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.seminhematol.2019.03.005","article-title":"Immune reconstitution after T-cell replete HLA-haploidentical transplantation","volume":"56","author":"McCurdy","year":"2019","journal-title":"Semin Hematol"},{"issue":"3","key":"2025120910563027700_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41409-024-02474-1","article-title":"Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis","volume":"60","author":"Meyer","year":"2024","journal-title":"Bone Marrow Transpl"},{"key":"2025120910563027700_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fimmu.2019.00782","article-title":"B cell reconstitution and influencing factors after hematopoietic stem cell transplantation in children","volume":"10","author":"van der Maas","year":"2019","journal-title":"Front Immunol"},{"issue":"5","key":"2025120910563027700_bib20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/joim.13776","article-title":"The dynamics of B-cell reconstitution post allogeneic hematopoietic stem cell transplantation: a real-world study","volume":"295","author":"Zhou","year":"2024","journal-title":"J Intern Med"},{"issue":"9","key":"2025120910563027700_bib21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcyt.2023.05.012","article-title":"Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis","volume":"25","author":"Troullioud Lucas","year":"2023","journal-title":"Cytotherapy"},{"issue":"2","key":"2025120910563027700_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbmt.2012.10.010","article-title":"Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children","volume":"19","author":"Bartelink","year":"2013","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2025120910563027700_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bmt.1705870","article-title":"Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality","volume":"41","author":"Berger","year":"2008","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"2025120910563027700_bib24","first-page":"174","article-title":"The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation","volume":"10","author":"Fedele","year":"2012","journal-title":"Blood Transfus"},{"issue":"15","key":"2025120910563027700_bib25","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/bloodadvances.2018029892","article-title":"Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation","volume":"3","author":"Waller","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"2025120910563027700_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-1293.2010.00857.x","article-title":"Late presentation of HIV infection: a consensus definition","volume":"12","author":"Antinori","year":"2011","journal-title":"HIV Med"},{"issue":"3","key":"2025120910563027700_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM199501193320303","article-title":"Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy","volume":"332","author":"Mackall","year":"1995","journal-title":"N Engl J Med"},{"issue":"23","key":"2025120910563027700_bib28","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1182\/blood-2016-06-724005","article-title":"Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution","volume":"128","author":"de Koning","year":"2016","journal-title":"Blood"},{"key":"2025120910563027700_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/asheducation-2015.1.215","article-title":"Immune reconstitution following stem cell transplantation","volume":"2015","author":"van den Brink","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2025120910563027700_bib30","doi-asserted-by":"crossref","first-page":"805189","DOI":"10.3389\/fped.2021.805189","article-title":"Serotherapy as graft-versus-host disease prophylaxis in haematopoietic stem cell transplantation for acute lymphoblastic leukaemia","volume":"9","author":"Keogh","year":"2021","journal-title":"Front Pediatr"},{"issue":"5","key":"2025120910563027700_bib31","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"issue":"23","key":"2025120910563027700_bib32","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood-2016-06-721936","article-title":"Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation","volume":"128","author":"Admiraal","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2025120910563027700_bib33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbmt.2008.11.027","article-title":"Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation","volume":"15","author":"Call","year":"2009","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"2025120910563027700_bib34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00280-020-04160-7","article-title":"Pharmacokinetics of alemtuzumab in pediatric patients undergoing ex vivo T-cell-depleted haploidentical hematopoietic cell transplantation","volume":"86","author":"Bhoopalan","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"2025120910563027700_bib35","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s40262-019-00782-0","article-title":"Population pharmacokinetics of alemtuzumab (Campath) in pediatric hematopoietic cell transplantation: towards individualized dosing to improve outcome","volume":"58","author":"Admiraal","year":"2019","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"2025120910563027700_bib36","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1038\/s41409-021-01460-1","article-title":"A prospective pilot study of a novel alemtuzumab target concentration intervention strategy","volume":"56","author":"Arnold","year":"2021","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"2025120910563027700_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/bcp.14955","article-title":"Model-informed precision dosing for alemtuzumab in paediatric and young adult patients undergoing allogeneic haematopoietic cell transplantation","volume":"88","author":"Dong","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"14","key":"2025120910563027700_bib38","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/bloodadvances.2018029421","article-title":"Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes","volume":"3","author":"Langenhorst","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"2025120910563027700_bib39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jcyt.2024.01.004","article-title":"Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients","volume":"26","author":"Lakkaraja","year":"2024","journal-title":"Cytotherapy"},{"issue":"4","key":"2025120910563027700_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41409-024-02206-5","article-title":"Individualized dose of anti-thymocyte globulin based on weight and pre-transplantation lymphocyte counts in pediatric patients: a single center experience","volume":"59","author":"Barriga","year":"2024","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"2025120910563027700_bib41","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.2020007905","article-title":"CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation","volume":"137","author":"de Koning","year":"2021","journal-title":"Blood"},{"issue":"9","key":"2025120910563027700_bib42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcyt.2020.05.005","article-title":"Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation","volume":"22","author":"van Roessel","year":"2020","journal-title":"Cytotherapy"},{"issue":"6","key":"2025120910563027700_bib43","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jaci.2016.12.992","article-title":"Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation","volume":"140","author":"Admiraal","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2025120910563027700_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.htct.2022.05.008","article-title":"Immune reconstitution after allogenic stem cell transplantation: an observational study in pediatric patients","volume":"45","author":"Belinovski","year":"2023","journal-title":"Hematol Transfus Cell Ther"},{"issue":"7","key":"2025120910563027700_bib45","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/cancers12071974","article-title":"Reconstitution of T cell subsets following allogeneic hematopoietic cell transplantation","volume":"12","author":"Dekker","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2025120910563027700_bib46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbmt.2008.11.038","article-title":"Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse","volume":"15","author":"Yakoub-Agha","year":"2009","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"2025120910563027700_bib47","doi-asserted-by":"crossref","first-page":"e0156777","DOI":"10.1371\/journal.pone.0156777","article-title":"Rapid recovery of CD3+CD8+ T cells on day 90 predicts superior survival after unmanipulated haploidentical blood and marrow transplantation","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"2025120910563027700_bib48","doi-asserted-by":"crossref","first-page":"e0204136","DOI":"10.1371\/journal.pone.0204136","article-title":"Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT","volume":"13","author":"Ranti","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"2025120910563027700_bib49","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41409-018-0351-x","article-title":"Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a Clinico-Biological EBMT Registry study mostly in the T-cell-depleted setting","volume":"54","author":"Bondanza","year":"2019","journal-title":"Bone Marrow Transpl"},{"issue":"16","key":"2025120910563027700_bib50","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1182\/bloodadvances.2019001032","article-title":"Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD","volume":"4","author":"Latis","year":"2020","journal-title":"Blood Adv"},{"key":"2025120910563027700_bib51","doi-asserted-by":"crossref","first-page":"1423689","DOI":"10.3389\/fimmu.2024.1423689","article-title":"A novel NKp80-based strategy for universal identification of normal, reactive and tumor\/clonal natural killer-cells in blood","volume":"15","author":"Mor\u00e1n-Plata","year":"2024","journal-title":"Front Immunol"},{"key":"2025120910563027700_bib52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fimmu.2017.00109","article-title":"Development of three different NK cell subpopulations during immune reconstitution after pediatric allogeneic hematopoietic stem cell transplantation: prognostic markers in GvHD and viral infections","volume":"8","author":"Huenecke","year":"2017","journal-title":"Front Immunol"},{"key":"2025120910563027700_bib53","doi-asserted-by":"crossref","first-page":"1005031","DOI":"10.3389\/fimmu.2022.1005031","article-title":"Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"13","author":"Mushtaq","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"2025120910563027700_bib54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv"},{"issue":"2","key":"2025120910563027700_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.2009.07768.x","article-title":"The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells","volume":"147","author":"Verneris","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"2025120910563027700_bib56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1365-2141.2001.02900.x","article-title":"Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children -- a Eurocord analysis","volume":"114","author":"Niehues","year":"2001","journal-title":"Br J Haematol"},{"issue":"13","key":"2025120910563027700_bib57","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2007-05-092130","article-title":"Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing","volume":"110","author":"Komanduri","year":"2007","journal-title":"Blood"},{"issue":"9","key":"2025120910563027700_bib58","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbmt.2006.05.008","article-title":"Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation","volume":"12","author":"Parkman","year":"2006","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"2025120910563027700_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.2023021336","article-title":"TCR\u03b1\u03b2\/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis","volume":"143","author":"Merli","year":"2024","journal-title":"Blood"},{"issue":"24","key":"2025120910563027700_bib60","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood-2018-07-861575","article-title":"Unrelated donor vs HLA-haploidentical \u03b1\/\u03b2 T-cell- and B-cell-depleted HSCT in children with acute leukemia","volume":"132","author":"Bertaina","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2025120910563027700_bib61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"key":"2025120910563027700_bib62","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3389\/fimmu.2018.01841","article-title":"Joint modeling of immune reconstitution post haploidentical stem cell transplantation in pediatric patients with acute leukemia comparing CD34(+)-selected to CD3\/CD19-depleted grafts in a retrospective multicenter study","volume":"9","author":"Salzmann-Manrique","year":"2018","journal-title":"Front Immunol"},{"issue":"12","key":"2025120910563027700_bib63","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bbmt.2016.09.006","article-title":"Early natural killer cell reconstitution predicts overall survival in T cell-replete allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Minculescu","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"2025120910563027700_bib64","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1007\/s00277-024-06084-1","article-title":"Prognostic significance of early NK cell recovery in pediatric t-cell replete allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Cui","year":"2024","journal-title":"Ann Hematol"},{"issue":"4","key":"2025120910563027700_bib65","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1182\/blood.2021013054","article-title":"Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning","volume":"139","author":"McCurdy","year":"2022","journal-title":"Blood"},{"issue":"10","key":"2025120910563027700_bib66","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/bmt.2017.122","article-title":"Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle Osseuse et Th\u00e9rapie Cellulaire and Eurocord","volume":"52","author":"Nguyen","year":"2017","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"2025120910563027700_bib67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clml.2016.06.013","article-title":"Post-transplantation natural killer cell count: a predictor of acute graft-versus-host disease and survival outcomes after allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Kim","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"2025120910563027700_bib69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbmt.2014.11.681","article-title":"Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome","volume":"21","author":"Pical-Izard","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"2025120910563027700_bib68","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bbmt.2018.10.013","article-title":"Innate immune recovery predicts CD4(+) T cell reconstitution after hematopoietic cell transplantation","volume":"25","author":"de Koning","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9","key":"2025120910563027700_bib70","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.bbmt.2017.05.005","article-title":"Humoral immune reconstitution kinetics after allogeneic hematopoietic stem cell transplantation in children: a maturation block of IgM memory B cells may lead to impaired antibody immune reconstitution","volume":"23","author":"Abdel-Azim","year":"2017","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"2025120910563027700_bib71","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/bloodadvances.2023010591","article-title":"Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study","volume":"8","author":"Bader","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"2025120910563027700_bib72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/v14010117","article-title":"The role of \u03b3\u03b4 T cells as a line of defense in viral infections after allogeneic stem cell transplantation: opportunities and challenges","volume":"14","author":"Janssen","year":"2022","journal-title":"Viruses"},{"key":"2025120910563027700_bib73","doi-asserted-by":"crossref","first-page":"971709","DOI":"10.3389\/fimmu.2022.971709","article-title":"Gamma delta T-cell reconstitution after allogeneic HCT: a platform for cell therapy","volume":"13","author":"Gaballa","year":"2022","journal-title":"Front Immunol"},{"issue":"15","key":"2025120910563027700_bib74","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2014-09-599423","article-title":"\u03b3\u03b4 T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-\u03b1\u03b2+\/CD19+ lymphocytes","volume":"125","author":"Airoldi","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2025120910563027700_bib75","doi-asserted-by":"crossref","first-page":"e13147","DOI":"10.1111\/ctr.13147","article-title":"Reconstitution of T and NK cells after haploidentical hematopoietic cell transplantation using \u03b1\u03b2 T cell-depleted grafts and the clinical implication of \u03b3\u03b4 T cells","volume":"32","author":"Park","year":"2018","journal-title":"Clin Transpl"},{"issue":"5","key":"2025120910563027700_bib76","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/scd.1.1996.5.503","article-title":"Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia","volume":"5","author":"Lamb","year":"1996","journal-title":"J Hematother"},{"issue":"1","key":"2025120910563027700_bib77","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbmt.2014.09.027","article-title":"Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia","volume":"21","author":"Perko","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"key":"2025120910563027700_bib78","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fimmu.2015.00365","article-title":"Thymic crosstalk coordinates medulla organization and T-cell tolerance induction","volume":"6","author":"Lopes","year":"2015","journal-title":"Front Immunol"},{"key":"2025120910563027700_bib79","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fimmu.2020.00371","article-title":"EuroFlow standardized approach to diagnostic immunopheneotyping of severe PID in newborns and young children","volume":"11","author":"Kalina","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"2025120910563027700_bib80","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2004.10.012","article-title":"Development of population-based newborn screening for severe combined immunodeficiency","volume":"115","author":"Chan","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"2025120910563027700_bib81","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3324\/haematol.2012.072264","article-title":"T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC\/\u03b2TREC ratio and thymic naive T cells","volume":"98","author":"Ringhoffer","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"2025120910563027700_bib82","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/cei.13062","article-title":"A comparison of TRECs and flow cytometry for naive T cell quantification","volume":"191","author":"Adams","year":"2018","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"2025120910563027700_bib83","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.V100.6.2235","article-title":"Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations","volume":"100","author":"Lewin","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2025120910563027700_bib84","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3324\/haematol.2011.047696","article-title":"Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients","volume":"96","author":"Wils","year":"2011","journal-title":"Haematologica"},{"issue":"9","key":"2025120910563027700_bib85","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jcyt.2024.04.073","article-title":"Immune recovery and the role of recent thymic emigrated T lymphocytes after pediatric hematopoietic stem cell transplantation","volume":"26","author":"Justus","year":"2024","journal-title":"Cytotherapy"},{"issue":"3","key":"2025120910563027700_bib86","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clim.2011.12.001","article-title":"Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival","volume":"142","author":"Sairafi","year":"2012","journal-title":"Clin Immunol"},{"issue":"10","key":"2025120910563027700_bib87","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/ijms17101705","article-title":"T cell receptor excision circle (TREC) monitoring after allogeneic stem cell transplantation; a predictive marker for complications and clinical outcome","volume":"17","author":"Gaballa","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2025120910563027700_bib88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fimmu.2013.00054","article-title":"Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapse","volume":"4","author":"Clave","year":"2013","journal-title":"Front Immunol"},{"issue":"14","key":"2025120910563027700_bib89","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1089\/scd.2013.0588","article-title":"T-cell receptor excision circle levels after allogeneic stem cell transplantation are predictive of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"23","author":"Uzunel","year":"2014","journal-title":"Stem Cells Dev"},{"key":"2025120910563027700_bib90","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3389\/fimmu.2018.02547","article-title":"Clinical T cell receptor repertoire deep sequencing and analysis: an application to monitor immune reconstitution following cord blood transplantation","volume":"9","author":"Gkazi","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"2025120910563027700_bib91","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"2025120910563027700_bib92","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"2025120910563027700_bib93","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008\/05\/30","journal-title":"Cell"},{"issue":"7","key":"2025120910563027700_bib94","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2025120910563027700_bib95","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat Immunol"},{"issue":"3","key":"2025120910563027700_bib96","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat Immunol"},{"issue":"8","key":"2025120910563027700_bib97","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2025120910563027700_bib98","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood-2015-10-672345","article-title":"Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD","volume":"127","author":"Alho","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2025120910563027700_bib99","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/bmt.2012.174","article-title":"Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease","volume":"48","author":"Reubsaet","year":"2013","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"2025120910563027700_bib100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/bmt.2012.176","article-title":"Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children","volume":"48","author":"Charrier","year":"2013","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"2025120910563027700_bib101","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI41072","article-title":"Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation","volume":"120","author":"Matsuoka","year":"2010","journal-title":"J Clin Invest"},{"issue":"7","key":"2025120910563027700_bib102","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood-2004-03-1040","article-title":"Association of Foxp3 regulatory gene expression with graft-versus-host disease","volume":"104","author":"Miura","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2025120910563027700_bib103","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/bmt.2014.105","article-title":"Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT","volume":"49","author":"Xhaard","year":"2014","journal-title":"Bone Marrow Transpl"},{"issue":"211","key":"2025120910563027700_bib104","doi-asserted-by":"crossref","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci Transl Med"},{"issue":"4","key":"2025120910563027700_bib105","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","article-title":"High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT","volume":"108","author":"Rezvani","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2025120910563027700_bib106","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbmt.2010.02.026","article-title":"Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease","volume":"16","author":"Magenau","year":"2010","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"2025120910563027700_bib107","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcyt.2020.01.005","article-title":"Rapid reconstitution of regulatory T-cell subsets is associated with reduced rates of acute graft-versus-host disease and absence of viremia after cord blood transplantation in children with reduced-intensity conditioning using alemtuzumab","volume":"22","author":"Chen","year":"2020","journal-title":"Cytotherapy"},{"issue":"16","key":"2025120910563027700_bib108","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","article-title":"High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease","volume":"115","author":"Luznik","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2025120910563027700_bib109","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1751-553X.2011.01300.x","article-title":"Kinetics of pDCs, mDCs, \u03b3\u03b4T cells and regulatory T cells in association with graft versus host disease after hematopoietic stem cell transplantation","volume":"33","author":"Watanabe","year":"2011","journal-title":"Int J Lab Hematol"},{"issue":"10","key":"2025120910563027700_bib110","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2011-04-347070","article-title":"NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions","volume":"118","author":"Foley","year":"2011","journal-title":"Blood"},{"issue":"7051","key":"2025120910563027700_bib111","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"2025120910563027700_bib112","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fimmu.2013.00458","article-title":"Impact of HCMV infection on NK cell development and function after HSCT","volume":"4","author":"Della Chiesa","year":"2013","journal-title":"Front Immunol"},{"issue":"2","key":"2025120910563027700_bib113","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaci.2022.10.022","article-title":"The diagnosis of severe combined immunodeficiency (SCID): the Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 definitions","volume":"151","author":"Dvorak","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2025120910563027700_bib114","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaci.2023.09.027","article-title":"Posttransplantation late complications increase over time for patients with SCID: a Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study","volume":"153","author":"Eissa","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"2025120910563027700_bib115","doi-asserted-by":"crossref","first-page":"e1040","DOI":"10.1002\/cti2.1040","article-title":"Contemporary analysis of functional immune recovery to opportunistic and vaccine-preventable infections after allogeneic haemopoietic stem cell transplantation","volume":"7","author":"de Silva","year":"2018","journal-title":"Clin Transl Immunol"},{"issue":"5","key":"2025120910563027700_bib116","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41409-023-01939-z","article-title":"Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party","volume":"58","author":"Greco","year":"2023","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"2025120910563027700_bib117","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbmt.2017.04.026","article-title":"Recommendations for screening and management of late effects in patients with severe combined immunodeficiency after allogenic hematopoietic cell transplantation: a consensus statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT","volume":"23","author":"Heimall","year":"2017","journal-title":"Biol Blood Marrow Transpl"},{"key":"2025120910563027700_bib118","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-3-030-94353-0_35","volume-title":"The EBMT\/EHA CAR-T Cell Handbook","author":"Berger","year":"2022"},{"issue":"10","key":"2025120910563027700_bib119","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1086\/598324","article-title":"Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2025120910563027700_bib120","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12185-016-2163-3","article-title":"Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at &gt;1 year after undergoing allogeneic hematopoietic stem cell transplantation","volume":"105","author":"Fukatsu","year":"2017","journal-title":"Int J Hematol"},{"issue":"6","key":"2025120910563027700_bib121","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3324\/haematol.2011.040386","article-title":"Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A\/09\/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients","volume":"96","author":"Mohty","year":"2011","journal-title":"Haematologica"},{"issue":"suppl 1","key":"2025120910563027700_bib122","doi-asserted-by":"crossref","first-page":"e14100","DOI":"10.1111\/tid.14100","article-title":"Vaccinations in children with hematologic malignancies and those receiving hematopoietic stem cell transplants or cellular therapies","volume":"25","author":"Neemann","year":"2023","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"2025120910563027700_bib127","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3122\/jabfm.17.1.59","article-title":"Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature","volume":"17","author":"Ebell","year":"2004","journal-title":"J Am Board Fam Med"},{"issue":"6","key":"2025120910563027700_bib123","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cytob.21158","article-title":"Establishment of harmonization in immunophenotyping: a comparative study of a standardized one-tube lymphocyte-screening panel","volume":"86","author":"Preijers","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"2025120910563027700_bib124","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cyto.b.21528","article-title":"A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters","volume":"94","author":"Keeney","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"2025120910563027700_bib125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cyto.b.21518","article-title":"AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia","volume":"94","author":"Dworzak","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"10","key":"2025120910563027700_bib126","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cyto.a.20623","article-title":"MIFlowCyt: the minimum information about a flow cytometry experiment","volume":"73","author":"Lee","year":"2008","journal-title":"Cytometry A"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/23\/6141\/2443049\/blooda_adv-2025-016915-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/23\/6141\/2443049\/blooda_adv-2025-016915-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:56:52Z","timestamp":1765295812000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/23\/6141\/547088\/Harmonized-immune-recovery-monitoring-after-HCT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":127,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016915","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,9]]},"published":{"date-parts":[[2025,12,2]]}}}